For this purpose, we investigated the biochemical and clinical–histological parameters that could impact on the [18F]Fluciclovine PET/CT positivity rate in a cohort of PCa patients with low PSA values in order to optimize its diagnostic performance and patient selection. Here, KLK3 is linked to posterior cortical atrophy.